HK1101545A1 - Use of a phenothiazine derivative for preventing and/or treating hearing loss - Google Patents

Use of a phenothiazine derivative for preventing and/or treating hearing loss

Info

Publication number
HK1101545A1
HK1101545A1 HK07106266.7A HK07106266A HK1101545A1 HK 1101545 A1 HK1101545 A1 HK 1101545A1 HK 07106266 A HK07106266 A HK 07106266A HK 1101545 A1 HK1101545 A1 HK 1101545A1
Authority
HK
Hong Kong
Prior art keywords
preventing
hearing loss
phenothiazine derivative
treating hearing
treating
Prior art date
Application number
HK07106266.7A
Other languages
English (en)
Inventor
Bernadette Pignol
Jean-Luc Puel
Serge Auvin
De Lassauniere Pierre-Etienne Chabrier
Jing Wang
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0403203A external-priority patent/FR2867979B1/fr
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of HK1101545A1 publication Critical patent/HK1101545A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07106266.7A 2004-03-29 2007-06-12 Use of a phenothiazine derivative for preventing and/or treating hearing loss HK1101545A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0403203A FR2867979B1 (fr) 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine
FR0406404 2004-06-14
PCT/FR2005/000713 WO2005092345A1 (fr) 2004-03-29 2005-03-25 Utilisation d’un derive de la phenothiazine pour la prevention et/ou le traitement de la perte d’audition

Publications (1)

Publication Number Publication Date
HK1101545A1 true HK1101545A1 (en) 2007-10-18

Family

ID=34968214

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07106266.7A HK1101545A1 (en) 2004-03-29 2007-06-12 Use of a phenothiazine derivative for preventing and/or treating hearing loss

Country Status (14)

Country Link
US (1) US7696197B2 (xx)
EP (1) EP1732567B1 (xx)
JP (1) JP5066444B2 (xx)
AR (1) AR048195A1 (xx)
AT (1) ATE410169T1 (xx)
CA (1) CA2560988A1 (xx)
DE (1) DE602005010222D1 (xx)
DK (1) DK1732567T3 (xx)
ES (1) ES2315868T3 (xx)
HK (1) HK1101545A1 (xx)
PL (1) PL1732567T3 (xx)
PT (1) PT1732567E (xx)
RU (1) RU2377992C2 (xx)
WO (1) WO2005092345A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954288B1 (fr) * 2005-10-21 2012-08-01 Ipsen Pharma Derives d'amidine et leurs applications a titre de medicament
FR2892415B1 (fr) * 2005-10-21 2007-11-30 Sod Conseils Rech Applic Derives d'amidine et leurs applications a titre de medicament
FR2898274B1 (fr) * 2006-03-07 2008-10-03 Sod Conseils Rech Applic Composition contenant des derives d'amidine ou de carboxamide et des steroides a titre de medicament
US8460639B2 (en) * 2008-12-25 2013-06-11 Canon Kabushiki Kaisha Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell
GB2467561A (en) * 2009-02-06 2010-08-11 Summit Corp Plc Dual calpain-ROS inhibitors
US20150150843A1 (en) * 2012-05-21 2015-06-04 Randall T. Peterson Cardioprotective compounds, their use with chemotherapy, and methods for identifying them
JP6542192B2 (ja) 2013-03-14 2019-07-10 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． Ｂｍｐ阻害剤およびその使用方法
RU2529700C1 (ru) * 2013-04-12 2014-09-27 Закрытое Акционерное Общество "Клинский институт охраны и условий труда "ОЛС-Комплект" Способ профилактики профессиональной потери слуха
US10513521B2 (en) 2014-07-15 2019-12-24 The Brigham And Women's Hospital, Inc. Compositions and methods for inhibiting BMP
WO2016033615A1 (en) * 2014-08-29 2016-03-03 Sound Pharmaceuticals Incorporated Methods of screening for drugs to prevent noise-induced hearing loss
JP6999896B2 (ja) 2017-09-21 2022-01-19 学校法人慶應義塾 音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149177A0 (en) * 1999-11-05 2002-11-10 Sod Conseils Rech Applic Novel heterocyclic compounds and their use as medicines
FR2816509B1 (fr) * 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
FR2863268B1 (fr) 2003-12-09 2006-02-24 Sod Conseils Rech Applic Nouveaux derives du 2-hydroxytetrahydrofuranne et leur application a titre de medicaments

Also Published As

Publication number Publication date
JP5066444B2 (ja) 2012-11-07
RU2377992C2 (ru) 2010-01-10
EP1732567A1 (fr) 2006-12-20
DK1732567T3 (da) 2009-02-09
WO2005092345A1 (fr) 2005-10-06
JP2007530640A (ja) 2007-11-01
US20080275034A1 (en) 2008-11-06
PT1732567E (pt) 2009-01-14
PL1732567T3 (pl) 2009-04-30
CA2560988A1 (fr) 2005-10-06
ES2315868T3 (es) 2009-04-01
RU2006138035A (ru) 2008-05-10
DE602005010222D1 (de) 2008-11-20
EP1732567B1 (fr) 2008-10-08
AR048195A1 (es) 2006-04-05
ATE410169T1 (de) 2008-10-15
US7696197B2 (en) 2010-04-13

Similar Documents

Publication Publication Date Title
HK1101545A1 (en) Use of a phenothiazine derivative for preventing and/or treating hearing loss
EP1750730A4 (en) TREATMENT OF HYPERCHOLESTERINEMIA, HYPERTRIGLYCERIDEMIA, AND HEART CIRCUIT-RELATED TREATMENTS USING PHOSPHALIPASE A2 INHIBITORS
EP1799129A4 (en) DEVICES AND METHODS FOR ABLATION OF FABRICS
ZA200605398B (en) Tibial insert and associated surgical method
IL169440A0 (en) Drug-coated stents and methods of use therefor
HK1186125A1 (en) Quinoline derivatives for the treatment of latent tuberculosis
EP1876997A4 (en) SLINGS FOR SUPPORTING AND CLOSING A TISSUE AND APPLICATION METHOD THEREFOR
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
IL179210A0 (en) Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
EP1942225A4 (en) PAPER PROCESSING AND PAPER PROCESSING METHOD
IL180737A0 (en) Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
EP1736173A4 (en) MEANS FOR THE TREATMENT OF TISSUE DAMAGE AND THERAPEUTIC PROCEDURE
GB0413068D0 (en) Treatment of pulp
EP1726313A4 (en) MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS
ZA200808076B (en) Methods for preventing and treating amyloidogenic diseases
GB2441094B (en) Methods for treatment and prevention of infection
ZA200705160B (en) Quinoline derivatives for the treatment of latent tuberculosis
EP1765797A4 (en) PHENOTHIAZINE DERIVATIVES AND METHODS OF USE
IL177105A0 (en) Coumarin derivative and use thereof
EP1843780A4 (en) Methods of Treatment
GB0421176D0 (en) Treatment of atherosclerosis
AU2005907328A0 (en) A method of treatment and agents useful for same
AU2004905148A0 (en) A method of treatment and agents useful for same
AU2004907322A0 (en) A method of treatment and agents useful for same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140325